imo csl made a big mistake buy most iof the u.s .a blood supply
seeming how blood products have a short shelf life and gdp can etxtract much higher yields you dont need a massive blood supply ( THIS IS THE MAIN REASON I WONT BUY CSL )
AS FOR GDP fractionation is aonly a small % of the total potention activities they could perform
it its also my opinion that gdp mis grossly under valued atm
this is bargain basement prices atm
investment stock or what
its been a 5 yr wait but should be more than worth it
imo $50 is a start once they are up and running
with a small j/v finding a test for madcow potential mkt $ 2.5 bill
imagine what else they could do just in the biologic tests dept
as a research tool it could be a standard
regards gaga
- Forums
- ASX - By Stock
- what do you think about that munch???????
what do you think about that munch???????, page-13
Featured News
Featured News
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online